DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Transactions / BioreclamationIVT
Thompson Street Capital Partners Recapitalizes BioreclamationIVT
Majority recapitalizationclosedannounced Jan 5, 2016closed Jan 5, 2016Fact
What happened
- Target
- BioreclamationIVT
- Platform
- not an add-on on record
- Control
- Control
- Share acquired
- unknown
- Industry
- healthcare / life sciences, pharma
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
2 named
Buy side
- “Thompson Street Capital Partners (TSCP), in partnership with Arsenal Capital Partners, a New York City-based management and investment firm, announced today that they have recapitalized BioreclamationIVT ( www.bioreclamationivt.com ). | published on Thompson Street Capital Manager's own news page ww”
Side not stated
- “Thompson Street Capital Partners (TSCP), in partnership with Arsenal Capital Partners, a New York City-based management and investment firm, announced today that they have recapitalized BioreclamationIVT ( www.bioreclamationivt.com ).”
Evidence
“Thompson Street Capital Partners (TSCP), in partnership with Arsenal Capital Partners, a New York City-based management and investment firm, announced today that they have recapitalized BioreclamationIVT ( www.bioreclamationivt.com ).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026